Hepatocellular carcinoma and cholangiocarcinoma are associated with high serum levels of hepatocyte growth factor
Balaban, Y.H.; Us, D.; Hascelik, G.; Bayraktar, Y.
Indian Journal of Gastroenterology Official Journal of the Indian Society of Gastroenterology 25(4): 223-224
2006
ISSN/ISBN: 0254-8860 PMID: 16974053 Document Number: 601228
Document emailed within 1 workday
Related Documents
Wu, J.C.; Merlino, G.; Cveklova, K.; Mosinger, B.; Fausto, N. 1994: Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1 Cancer Research 54(22): 5964-5973Hioki, O.; Watanabe, A.; Minemura, M.; Tsuchida, T. 1993: Clinical significance of serum hepatocyte growth factor levels in liver diseases Journal of Medicine 24(1): 35-46
Ru, G.-q.; Zhao, Z.-s.; Tang, Q.-l.; Xu, W.-j. 2008: MRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof Zhonghua Yi Xue Za Zhi 88(29): 2030-2035
Ito, N.; Kawata, S.; Tamura, S.; Takaishi, K.; Shirai, Y.; Kiso, S.; Yabuuchi, I.; Matsuda, Y.; Nishioka, M.; Tarui, S. 1991: Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma Cancer Research 51(15): 4080-4083
Zhong, C.; Wei, W.; Su, X-Kang.; Li, H-Dong.; Xu, F-Bing.; Guo, R-Ping. 2012: Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection Hepato-Gastroenterology 59(113): 93-97
Su, Q.; Liu, Y. 1995: Expression of c-myc, c-erbB-2, insulin-like growth factor Ii andepidermal growth factor receptor in hepatitis B, cirrhosis and hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 75(3): 144-146; 189
Leelawat, K.; Laisupasin, P.; Kiatdilokrut, A.; Pongtongpool, T.; Narong, S.; Samkhumphim, N.; Ket-Horm, S. 2008: The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE) Journal of the Medical Association of Thailand 91(10): 1539-1543
Nishizaki, T.; Takenaka, K.; Yoshizumi, T.; Yanaga, K.; Soejima, Y.; Shirabe, K.; Sugimachi, K. 1995: Alteration in levels of human hepatocyte growth factor following hepatectomy Journal of the American College of Surgeons 181(1): 6-10
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645
Wang, N-fu.; Tong, G-xin.; Li, P-zhang.; Zhang, X-wei.; Xu, J.; Wu, G-ping.; Jin, J-fen.; Zhou, L.; Ye, X-hua.; Yang, J-min.; Pan, H. 2007: Changes of serum hepatocyte growth factor before and after percutaneous coronary intervention in patients with unstable angina pectoris and significance there Zhonghua Yi Xue Za Zhi 87(20): 1411-1413
Yoshioka, T.; Morimoto, Y.; Iwagaki, H.; Itoh, H.; Saito, S.; Kobayashi, N.; Yagi, T.; Tanaka, N. 2001: Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells Journal of International Medical Research 29(5): 409-420
Oe, H.; Kaido, T.; Mori, A.; Onodera, H.; Imamura, M. 2005: Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats Hepato-Gastroenterology 52(65): 1393-1397
Suzuki, K.; Hayashi, N.; Miyamoto, Y.; Yamamoto, M.; Ohkawa, K.; Ito, Y.; Sasaki, Y.; Yamaguchi, Y.; Nakase, H.; Noda, K.; Enomoto, N.; Arai, K.; Yamada, Y.; Yoshihara, H.; Tujimura, T.; Kawano, K.; Yoshikawa, K.; Kamada, T. 1996: Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma Cancer Research 56(13): 3004-3009
Lindgren, B.F.; Segovia, B.; Lassarre, C.; Binoux, M.; Gourmelen, M. 1996: Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-i and to its reduced bioavailability Growth Regulation 6(3): 158-164
Wu, X.; Peng, L. 1997: Expression of epidermal growth factor and its receptor in human primary hepatocellular carcinoma Hunan Yi Ke da Xue Xue Bao 22(6): 544-546
Matyja, V.; Kos-Kudla, B.; Foltyn, W.; Strzelczyk, J.; Latos, W.; Marek, B.; Kajdaniuk, D.; Karpe, J.; Ostrowska, Z.; Sieron-Stoltny, K.; Sieron, A. 2006: Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels Neuro Endocrinology Letters 27(5): 639-643
Sipos, F.; Molnár, B.él.; Zágoni, T.ás.; Miheller, P.ál.; Tulassay, Z. 2006: Insulin-like growth factor receptor, hepatocyte-derived growth factor receptor and telomerase expression in ulcerative colitis Orvosi Hetilap 147(38): 1835-1841
Park, M.Young.; Kim, K.Ryoul.; Park, H.Sung.; Park, B-Hyun.; Choi, H.Na.; Jang, K.Yun.; Chung, M.Ja.; Kang, M.Jae.; Lee, D.Geun.; Moon, W.Sung. 2007: Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition International Journal of Oncology 31(6): 1309-1315
Takeda, S.; Kondo, M.; Kumada, T.; Koshikawa, T.; Ueda, R.; Nishio, M.; Osada, H.; Suzuki, H.; Nagatake, M.; Washimi, O.; Takagi, K.; Takahashi, T.; Nakao, A.; Takahashi, T. 1996: Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease Oncogene 12(7): 1589-1592
Terada, T.; Nakanuma, Y. 1993: An immunohistochemical survey of amylase isoenzymes in cholangiocarcinoma and hepatocellular carcinoma Archives of Pathology and Laboratory Medicine 117(2): 160-162